Displaying 1 - 1 of 1
| Active Ingredient | TRANEXAMIC ACID |
| Therapeutic Class | ANTIHEMORRHAGIC AGENTS |
| Indications | Treatment and prophylaxis of haemorrhage associated with excessive fibrinolysis. |
| Caution | Gastrointestinal disturbances, hypotension, dizziness, visual disturbances and musculoskeletal. |
| Dose Range | 1 to 1.5 g (or 15 to 25 mg/kg) 2 or 3 times daily . Slow intravenous injection: 0.5 to 1g 3 times daily (or 10 mg/kg is given 3 or 4 times daily ). |
| Drug Interactions | |
| Pregnancy | Manufacturer advises use only if potential benefit outweighs risk. |
| Breast Feeding |